The first treatment developed for chronic hepatitis B was interferon(IFN),and more recently long‐acting pegy‐lated IFN‐α has been shown to be more effective .There is level Ⅱ b evidence that IFN treatment reduces HCC risk,particularly at the stage of cirr ......